Læknablaðið - 15.11.1991, Page 37

LÆKNABLAÐIÐ
359
of the protective efficacy of pneumococcal vaccine
for patients at high risk of serious pneumococcal
infeclion. Ann Intem Med 1984; 101: 325-30.
12. Sims RV, Steinmann WC, McConville JH, King LR,
Zwick WC, Schwartz JS. The clinical effectiveness
of the pneumococcal vaccine in the elderly. Ann
Intem Med 1988; 108; 653-7.
13. Dreifibréf Landlæknisembættisins nr. 4/1991.
Læknablaðið/Fréttabréf lækna 1991; 9(5); 14-5.
14. Lin KT, Lee CJ. Immune respsonse of neonates to
pneumococcal polysaccharine protein conjugate.
Immunology 1982; 46: 333-42.
15. Coen Beuvery E, vanRossum F, Nagel J. Comparsion
of the Induction of Immunoglobulin M and G
Antibodies in Mice with Purified Pneumococcal Type
3 and Meningococcal Group C Polysaccharides and
their Protein Conjugates. Infect Immun 1982; 37: 15-
22.
16. Schneerson R, Robbins JB, Parke JC, et al.
Quatitative and Qualitative Analysis of Serum
Antibodies Elicited in Adults by Haemophilus
Influenzae Type B and Pneumococcus Type 6A
Capsular Polysaccharide-Tetanus Toxoid Conjugates.
Infect Immun 1986; 52: 519-28.
17. Bardardottir E, Jonsson S, Jonsdottir I, Sigfusson
A, Valdimarsson H. IgG Subclass response and
opsonization of Streptococcus pneumoniae after
Vaccination of Healthy Adults. J lnfect Dis 1990;
162: 482-8.
18. Eskola J, Peltola H, Takala AK, et al.
Efficacy of Haemophilus influenzae type b
polysaccharidediphtheria toxoid conjugate vaccine
in infancy. N Engl J Med 1987; 317: 717-22.
19. Eskola J, Kayhty H, Takala AK, et al. A randomized,
prospective field trial of a conjugate vaccine in the
protection of infants and young children against
invasive Haemopliilus influenzae type b disease. N
Engl J Med 1990; 323: 1381-7.